Qiagen (QGEN) Current Deferred Revenue (2009 - 2010)
Qiagen (QGEN) posted Current Deferred Revenue of $21.0 million for Q4 2010, up 31.55% sequentially from $15.9 million in Q4 2009, and up 31.55% YoY from $15.9 million in Q4 2009.
Qiagen (QGEN) Current Deferred Revenue (2009 - 2010) Analysis & Trends
Qiagen has reported Current Deferred Revenue for 2 years, with the latest figure at $21.0 million in Q4 2010.
- Quarterly Current Deferred Revenue rose 31.55% year-over-year to $21.0 million in Q4 2010, while the trailing twelve-month figure through Dec 2010 was $21.0 million (up 31.55% YoY) and the FY2010 annual result came in at $21.0 million, up 31.55% from the prior year.
- Current Deferred Revenue advanced to $21.0 million in Q4 2010 per QGEN's latest filing, from $15.9 million in the prior quarter.
- Over five years, Current Deferred Revenue peaked at $21.0 million in Q4 2010 and troughed at $15.9 million in Q4 2009.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn |
| 10 | Qiagen | 9.49 Bn | 8.72 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2010 | 20.97 Mn |
| Dec 31, 2009 | 15.94 Mn |